Current Neuropharmacology · 2020 · 11 citations · 50 references
Life SciencesNeurosciencePharmacologyCell SignalingMolecular NeuroscienceSignal TransductionAntiepileptic PharmacologyNeuroprotectionNeurotransmissionRetinoic Acid SignalingHippocampal Long-term PotentiationMechanisms Of Seizure ControlNeuronal Gap JunctionsNeuronal Gene TranscriptionNongenomic SignalingRetinoid Receptor SignalingRetinoid ReceptorsRetinoid X Receptors
Retinoic acid, a metabolite of vitamin A, acts through either genomic or nongenomic actions. The genomic action of retinoids exerts effects on gene transcription through interaction with retinoid receptors such as retinoic acid receptors (RARα, β, and γ) and retinoid X receptors (RXRα, β, and γ) that are primarily concentrated in the amygdala, pre-frontal cortex, and hippocampal areas in the brain. In response to retinoid binding, RAR/RXR heterodimers undergo major conformational changes and orchestrate the transcription of specific gene networks. Previous experimental studies have reported that retinoic acid exerts an antiepileptogenic effect through diverse mechanisms, including the modulation of gap junctions, neurotransmitters, long-term potentiation, calcium channels and some genes. To our knowledge, there are no previous or current clinical trials evaluating the use of retinoic acid for seizure control.
50
The epidemiology of epilepsy revisited
Josemir W. Sander · Current Opinion in Neurology · 2003 · 681 citations
A role for leukocyte-endothelial adhesion mechanisms in epilepsy
Paolo Francesco Fabene, Graciela Navarro Mora, Marianna Martinello et al. · Nature Medicine · 2008 · 502 citations · Full text
Retinoid-binding proteins: mediators of retinoid action
Noa Noy · Biochemical Journal · 2000 · 362 citations · Full text